Home > Research > Publications & Outputs > Prospective donors’ perspectives on hematopoiet...

Electronic data

  • RME-2022-0195_Proof_hi

    Rights statement: 12

    Accepted author manuscript, 802 KB, PDF document

    Embargo ends: 1/01/50

    Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License

View graph of relations

Prospective donors’ perspectives on hematopoietic cell donation for cell and gene therapy research and development

Research output: Contribution to Journal/MagazineJournal articlepeer-review

<mark>Journal publication date</mark>16/02/2023
<mark>Journal</mark>Regenerative Medicine
Publication StatusAccepted/In press
<mark>Original language</mark>English


Aims: To explore prospective donors’ attitudes and perceptions towards donating hematopoietic stem cells (HSCs) for novel treatments research and development (R&D).
Methods: A survey was launched by Anthony Nolan (AN) to assess prospective donors’ willingness to donate HSCs for novel therapies R&D, and their degree of comfort with the AN collaborating with and receiving payment from external organizations.
Results: Most participants (87%) were willing to donate for novel treatment R&D and were comfortable with AN collaborating with external organizations and receiving payment (91% and 80%, respectively).
Conclusion: Results reveal an overall positive response towards donating HSCs for R&D. These findings can support stakeholders and policymakers in outlining donation practices that uphold donors’ safety and welfare.